COVID-19快速反应护士分诊结局:患者参与分诊建议的相关因素
该队列研究基于2020年3月至2021年3月四个季度的电子健康记录,评估COVID-19热线护士分诊后患者对建议的参与率(遵从护士分诊建议的患者百分比)及其相关因素。共纳入9849次接触/来电、来自9021名唯一参与者。结果显示总体参与率为72.5%,被建议急诊就诊者参与率最低(43.4%);参与与较年长、较低合并症指数、无不明原因肌肉酸痛及呼吸道症状相关。无呼吸道症状是四个阶段均显著相关的唯一因素(OR分别为0.75、0.60、0.64、0.52),较年长在四个阶段中的三个阶段与更高参与相关(OR=1.01-1.02),较低Charlson合并症指数在第三和第四阶段与更高参与相关(OR=0.83、0.88)。作者认为该研究支持使用护士主导的远程医疗干预,并强调对高风险群体及时随访的重要性。
要点
- 总体患者参与率为72.5%(9849次接触/来电,来自9021名唯一参与者)。
- 被建议急诊就诊者参与率最低,仅43.4%。
- 无呼吸道症状是四个阶段均与患者参与显著相关的唯一因素(OR=0.75、0.60、0.64、0.52)。
- 较年长在四个阶段中的三个阶段与更高参与相关(OR=1.01-1.02)。
- 较低Charlson合并症指数在第三和第四阶段与更高参与相关(OR=0.83、0.88)。
适用人群与场景
- 所有提供症状(包括无症状但有COVID暴露)并接受护士分诊的来电者。
- 研究场景为COVID-19热线电话分诊与建议服务。
- 研究期间为2020年3月至2021年3月,分四个季度阶段:第一阶段2020年3月14日至2020年6月6日;第二阶段2020年6月17日至2020年9月16日;第三阶段2020年9月17日至2020年12月16日;第四阶段2020年12月17日至2021年3月16日。
研究设计与关键结果
- 研究类型为队列研究,基于2020年3月至2021年3月四个季度的电子健康记录。
- 共纳入9849次接触/来电,来自9021名唯一参与者。
- 总体患者参与率(遵从护士分诊建议的患者百分比)为72.5%。
- 被建议急诊就诊者的患者参与率最低,为43.4%。
- 无呼吸道症状是四个阶段均与患者参与显著相关的唯一因素(OR=0.75、0.60、0.64、0.52)。
- 较年长在四个阶段中的三个阶段与更高患者参与相关(OR=1.01-1.02)。
- 较低Charlson合并症指数在第三和第四阶段与更高患者参与相关(OR=0.83、0.88)。
- 患者参与与较年长、较低合并症指数、无不明原因肌肉酸痛及呼吸道症状相关。
证据类型、等级与局限
- 证据类型:队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,本研究支持使用护士主导的远程医疗干预。
- 作者认为,本研究揭示与患者参与相关的关键因素,并强调在COVID-19大流行期间对高风险群体及时随访的重要性,以及护士作为医疗导航者主导远程医疗干预的益处。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: COVID-19 is an ongoing global health crisis with prevention and treatment recommendations rapidly changing. Rapid response telephone triage and advice services are critical in providing timely care during pandemics. Understanding patient participation with triage recommendations and factors associated with patient participation can assist in developing sensitive and timely interventions for receiving the treatment to prevent adverse health effects of COVID-19.
METHODS: This cohort study aimed to assess patient participation (percentage of patients who followed nursing triage suggestions from the COVID hotline) and identify factors associated with patient participation in four quarterly electronic health records from March 2020 to March 2021 (Phase 1: 14 March 2020-6 June 2020; Phase 2: 17 June 2020-16 September 2020; Phase 3: 17 September 2020-16 December 2020; Phase 4: 17 December 2020-16 March 2021). All callers who provided their symptoms (including asymptomatic with exposure to COVID) and received nursing triage were included in the study. Factors associated with patient participation were identified using multivariable logistic regression analyses, including demographic variables, comorbidity variables, health behaviors, and COVID-19-related symptoms.
RESULTS: The aggregated data included 9849 encounters/calls from 9021 unique participants. Results indicated: (1) 72.5% of patient participation rate; (2) participants advised to seek emergency department care had the lowest patient participation rate (43.4%); (3) patient participation was associated with older age, a lower comorbidity index, a lack of unexplained muscle aches, and respiratory symptoms. The absence of respiratory symptoms was the only factor significantly associated with patient participation in all four phases (OR = 0.75, 0.60, 0.64, 0.52, respectively). Older age was associated with higher patient participation in three out of four phases (OR = 1.01-1.02), and a lower Charlson comorbidity index was associated with higher patient participation in phase 3 and phase 4 (OR = 0.83, 0.88).
CONCLUSION: Public participation in nursing triage during the COVID pandemic requires attention. This study supports using a nurse-led telehealth intervention and reveals crucial factors associated with patient participation. It highlighted the importance of timely follow-up in high-risk groups and the benefit of a telehealth intervention led by nurses serving as healthcare navigators during the COVID-19 pandemic.
参考来源
- Chen JL, Lin CX, Park M, et al. Rapid response nursing triage outcomes for COVID-19: factors associated with patient's participation in triage recommendations. BMC Med Inform Decis Mak. 2023. PMID: 36890538. doi:10.1186/s12911-023-02139-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。